ADHD-medication and psychosis; case report and literature review

The treatment of attention-deficit/hyperactivity disorder (ADHD) largely involves the pharmacological restoration of dopaminergic hypoactivity in the brain, specifically in the prefrontal cortex. A disruption in dopaminergic neurotransmission is also seen in schizophrenia and psychosis, where there is a hyperactivity of this neurotransmitter. In our case study, a man with ADHD developed psychosis during treatment with stimulants. We investigate whether stimulants have a risk-modulating effect on…

via https://pubmed.ncbi.nlm.nih.gov/40785566/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250827010905&v=2.18.0.post9+e462414